DDX20 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 4.0529801736966E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.7182999996529E-07 |
Normal-vs-Stage2 |
2.031900E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
3.402500E-03 |
Stage1-vs-Stage2 |
7.586200E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
9.618500E-02 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
9.300400E-02 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.07859976295322E-10 |
Normal-vs-AfricanAmerican |
2.052000E-01 |
Normal-vs-Asian |
1.456160E-02 |
Caucasian-vs-AfricanAmerican |
3.374600E-01 |
Caucasian-vs-Asian |
5.840000E-01 |
AfricanAmerican-vs-Asian |
5.878000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.73192999999294E-05 |
Normal-vs-Female |
1.39139999966176E-07 |
Male-vs-Female |
6.675000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.427100E-04 |
Normal-vs-Extreme_Weight |
4.14880000000339E-05 |
Normal-vs-Obese |
3.771800E-04 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
3.332800E-01 |
Normal_Weight-vs-Obese |
2.207600E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
9.963600E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.699800E-01 |
Normal-vs-Age(41-60Yrs) |
1.188760E-04 |
Normal-vs-Age(61-80Yrs) |
8.42030000169913E-08 |
Normal-vs-Age(81-100Yrs) |
4.576400E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.689400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.775800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.218800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.418000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.371800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.990000E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
1.450990E-01 |
Normal-vs-Grade 3 |
1.518220E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
6.264200E-01 |
Grade 2-vs-Grade 4 |
1.450990E-01 |
Grade 3-vs-Grade 4 |
1.518220E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.14309994592566E-09 |
Normal-vs-N1 |
1.212280E-02 |
N0-vs-N1 |
3.146200E-01 |
|
|